{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T18:21:56Z","timestamp":1775586116849,"version":"3.50.1"},"reference-count":57,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006671","name":"Maryland Department of Health and Mental Hygiene","doi-asserted-by":"publisher","award":["128188"],"award-info":[{"award-number":["128188"]}],"id":[{"id":"10.13039\/100006671","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Behavioral Health System Baltimore","award":["AS019-HRO-JHPH"],"award-info":[{"award-number":["AS019-HRO-JHPH"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01DA046234"],"award-info":[{"award-number":["K01DA046234"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine"],"published-print":{"date-parts":[[2023,12,12]]},"DOI":"10.1080\/07853890.2023.2196435","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T16:39:32Z","timestamp":1682008772000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA)"],"prefix":"10.1080","volume":"55","author":[{"given":"Sean T.","family":"Allen","sequence":"first","affiliation":[{"name":"Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5813-1327","authenticated-orcid":false,"given":"Kristin E.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"Rouhani","sequence":"additional","affiliation":[{"name":"Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7894-4114","authenticated-orcid":false,"given":"Rebecca Hamilton","family":"White","sequence":"additional","affiliation":[{"name":"Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Owczarzak","sequence":"additional","affiliation":[{"name":"Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan G.","family":"Sherman","sequence":"additional","affiliation":[{"name":"Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"e_1_3_5_2_1","volume-title":"Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2020","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health. Rockville (MD): Center for Behavioral Health Statistics and Quality; 2020."},{"key":"e_1_3_5_3_1","volume-title":"Overdose deaths accelerating during COVID-19","author":"CDC","year":"2020","unstructured":"CDC. Overdose deaths accelerating during COVID-19. Atlanta (GA): CDC; 2020."},{"key":"e_1_3_5_4_1","volume-title":"Drug overdose deaths in the U.S. top 100,000 annually","author":"CDC","year":"2021","unstructured":"CDC. Drug overdose deaths in the U.S. top 100,000 annually. Atlanta (GA): CDC; 2021."},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7006a4"},{"key":"e_1_3_5_6_1","volume-title":"Nonfatal drug overdoses increased during COVID-19 pandemic","author":"Minnesota Department of Health","year":"2021","unstructured":"Minnesota Department of Health. Nonfatal drug overdoses increased during COVID-19 pandemic. 2021. Available at: https:\/\/www.health.state.mn.us\/news\/pressrel\/2021\/overdose093021.html"},{"key":"e_1_3_5_7_1","unstructured":"Zibbell JH Clark SD Ferrell A et\u00a0al. Non-fatal opioid overdose and associated health outcomes: final summary report. 2019. RTI International. Available at: https:\/\/aspe.hhs.gov\/reports\/non-fatal-opioid-overdose-associated-health-outcomes-final-summary-report-0"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32229-9"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.96811135.x"},{"issue":"16","key":"e_1_3_5_10_1","first-page":"443","article-title":"Community outbreak of HIV infection linked to injection drug use of oxymorphone\u2013Indiana, 2015","volume":"64","author":"Conrad C","year":"2015","unstructured":"Conrad C, Bradley HM, Broz D, et\u00a0al. Community outbreak of HIV infection linked to injection drug use of oxymorphone\u2013Indiana, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(16):443\u2013444.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.07.008"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15151"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2020.81.740"},{"key":"e_1_3_5_14_1","unstructured":"CDC. HIV and substance use. 2021. Centers for Disease Control and Prevention. Available at: https:\/\/www.cdc.gov\/hiv\/basics\/hiv-transmission\/injection-drug-use.html"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000075"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta11090"},{"key":"e_1_3_5_17_1","first-page":"Cd004145","article-title":"Substitution treatment of injecting opioid users for prevention of HIV infection","volume":"2","author":"Gowing L","year":"2008","unstructured":"Gowing L, et\u00a0al. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2008;(2):Cd004145.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-006-0258-x"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2009.10.006"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2021.100029"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.4001"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108146"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000045"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.01.015"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2013.0152"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2008.07.004"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00176-8"},{"issue":"3","key":"e_1_3_5_28_1","first-page":"Cd002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick RP","year":"2009","unstructured":"Mattick RP, Breen C, Kimber J, et\u00a0al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;2009(3):Cd002209.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.190344"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2016.1100960"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00584-3"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103548"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108984"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00412-0"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02754.x"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2009.00100.x"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02185.x"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15601"},{"issue":"2","key":"e_1_3_5_39_1","first-page":"17","article-title":"The role and function of heroin assisted treatment at the treatment system level","volume":"19","author":"Uchtenhagen A.","year":"2017","unstructured":"Uchtenhagen A. The role and function of heroin assisted treatment at the treatment system level. Heroin Addict Relat Clin Prob. 2017;19(2):17\u201324.","journal-title":"Heroin Addict Relat Clin Prob"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.160986"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.149195"},{"key":"e_1_3_5_42_1","unstructured":"Alliance DP. Heroin-assisted treatment. 2023. Drug Policy Alliance. Available at: https:\/\/drugpolicy.org\/issues\/HAT"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14442"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.7249\/RR2693"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06529-1"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7410.310"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810635"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.04.007"},{"key":"e_1_3_5_49_1","doi-asserted-by":"crossref","unstructured":"Smart R. Evidence on the effectiveness of heroin-assisted treatment. 2018. RAND Corporation. Available at: https:\/\/www.rand.org\/pubs\/working_papers\/WR1263.html","DOI":"10.7249\/WR1263"},{"key":"e_1_3_5_50_1","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). MAT medications counseling and related conditions. 2023. https:\/\/www.samhsa.gov\/medication-assisted-treatment\/medications-counseling-related-conditions\/buprenorphine"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2021.107215"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103426"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00466-8"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-018-0292-0"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-8-9"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.11363"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14608"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.10.015"}],"container-title":["Annals of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/07853890.2023.2196435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T19:27:21Z","timestamp":1705433241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07853890.2023.2196435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,12]]}},"alternative-id":["10.1080\/07853890.2023.2196435"],"URL":"https:\/\/doi.org\/10.1080\/07853890.2023.2196435","relation":{},"ISSN":["0785-3890","1365-2060"],"issn-type":[{"value":"0785-3890","type":"print"},{"value":"1365-2060","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-10-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2196435"}}